You are here: Industry Insights > Diabetes

News List

Canagliflozin may not be associated with fracture risk in diabetes patients europeanpharmaceuticalreview
January 03, 2019
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes…
Novo taps e-therapeutics for diabetes target discovery drive fiercebiotech
December 28, 2018
Novo Nordisk has enlisted e-therapeutics to support target discovery efforts at its recently-opened research center in Oxford, U.K. .....
Lilly lays out sunny 2019 forecast driven by growth of new diabetes, psoriasis and cancer drugs fiercepharma
December 25, 2018
Shares of Eli Lilly were up nearly 3% in premarket trading on Wednesday after the company provided a revenue and profit forecast for next year that beat analysts’ expectations.
Lilly lays out sunny 2019 forecast driven by growth of new diabetes, psoriasis and cancer drugs fiercepharma
December 20, 2018
Shares of Eli Lilly were up nearly 3% in premarket trading on Wednesday after the company provided a revenue and profit forecast for next year that beat analysts’ expectations.
Sandoz Enters Into Commercialization, Supply Agreement for Insulin Biosimilars americanpharmaceuticalreview
December 20, 2018
Sandoz has entered into an agreement to commercialize biosimilar versions of insulins used in patients with type 1 and type 2 diabetes.....
Amazon sells exclusive diabetes and hypertension devices pharmaphorum
December 18, 2018
Amazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at home.The Choice devices, produced by the healthcare consultancy....
Diabetes-related lower limb amputations jump nearly 20% pharmatimes
December 18, 2018
A new report from Diabetes UK shows that there were 26,378 lower limb amputations related to diabetes in England from 2014 to 2017, marking an increase of 19.4% from the previous three years.
Drug cocktail turns off the juice to cancer cells worldpharmanews
December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth - this was discovered by researchers from the University of Basel's Biozentrum two years ago.
Novo Nordisk and e-therapeutics alliance to focus on type-2 diabetes pharmaceutical-technology
December 12, 2018
Novo Nordisk has entered into research collaboration with UK-based E-therapeutics for the development of new treatment strategies for a specific area of type-2 diabetes.....
Diabetes like me? Survey finds older people with diabetes want to see familiar families in ads fiercepharma
December 10, 2018
Older Americans with diabetes see advertising differently than their peers. That’s according to a new YouGov survey that found 39% of people with diabetes aged 50 and older want to see more ads with....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page